MMRGlobal to Present the Future of Personal Health at B. Riley & Co. Investor Conference

LOS ANGELES, CA--(Marketwire - May 18, 2012) - Robert H. Lorsch, Chairman and Chief Executive Officer of MMRGlobal, Inc. (OTCBB: MMRF) ("MMR"), a leading provider of Personal Health Records (PHRs) and electronic document management and imaging systems for healthcare professionals, will address the opportunities in health information technology, in particular as it relates to Personal Health Records, at the 13^th Annual B. Riley & Co. Investor Conference on Monday, May 21, 2012 at 3:00 p.m. Pacific Time. The three-day, invitation-only conference at Loews Santa Monica Beach Hotel will be attended by an estimated 1,000 institutional, private equity and venture capital investors and senior company executives.

According to recent industry reports, Personal Health Record software sales are projected to be $414.8 million in 2015 (Frost & Sullivan) and the market value for telemedicine/remote patient monitoring is expected to reach $22 billion by the same year (Kalorama). Telemedicine and remote patient monitoring are already deployed in MMRGlobal's MyMedicalRecords Personal Health Record as part of the PHR inbox at no additional cost.

In his presentation, Lorsch will discuss how the Company plans on distributing its MyMedicalRecords PHR products and services at retail using prepaid Personal Health Record cards, through home healthcare agencies, local pharmacies, visiting nurses and patient advocates in addition to established channels including direct-to-consumers, through healthcare professionals, and as an affinity or membership benefit. The Company will also present its MMRPro document management and imaging system sold to physician practices, surgery centers, small hospitals and other healthcare professionals. MMRPro is also sold to help physicians migrate to an EMR solution. The MMRPro system comes with MMRPatientView as an integrated patient portal. Through a partnership with Interbit Data, MMRPatientView is already being installed in hospitals and is certified for Meaningful Use with MEDITECH systems.

MMR believes it has a competitive edge for the future from strategic partnerships with UST Global®, Regent Surgical Health, Chartis Insurance (formerly AIG), Alcatel-Lucent, ng Connect, 4medica, Interbit Data, MedicAlert®, Vida Senior Resource, VisiInc PLC and Unis-Tonghe in China. The Company also maintains a large portfolio of intellectual property in health IT with patents issued, pending or applied for in more than 13 countries. The Company's Personal Health Records patent portfolio has been the subject of worldwide rigorous examination and creates a significant licensing opportunity to companies providing Electronic Medical Records or electronic health information services globally.

Although MMRGlobal's primary business is in health IT, through its merger with Favrille, Inc. in January 2009, the Company now has patents and patent applications pending in the U.S. and at least 11 foreign countries of commercial interest. The Company spent more than $140 million in development of the biotech assets which are comprised of patents, patient samples and data from the FavId™/Specifid™ idiotype vaccine trials and proprietary anti-CD20 antibody panels to treat B-cell lymphoma. MMR has already licensed certain of its biotech assets on a non-exclusive basis for milestone payments of $13 million.

About MMRGlobal, Inc.
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video tutorials of the Company's products and services at www.mmrtheater.com.

Forward-Looking Statements

Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements, and some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," "help" and "continue," or the negative of such terms and other comparable terminology. MMRGlobal, Inc. disclaims any intent or obligation to revise or update any forward-looking statements. These forward-looking statements are based on MMRGlobal, Inc.'s reasonable expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially from current expectations. The information discussed in this release is subject to various risks and uncertainties related but not limited to changes in MMRGlobal, Inc.'s business prospects; its results of operations or financial condition; current uncertainty and instability in financial and lending markets including global economic uncertainties; the risk the Company's products are not adopted or viewed favorably by the healthcare community; the ability to establish and maintain strategic relationships; new product offerings; marketing and sales channels; competitive product offerings and promotions; regulation and changes in healthcare initiatives; maintaining, developing and defending our intellectual property rights; licensing and exploitation of our patent portfolio both in the U.S. and internationally; and such other risks and uncertainties as detailed from time to time in MMRGlobal, Inc.'s public filings with the U.S. Securities and Exchange Commission.